• SENSEX
    NIFTY 50
Market

CNBCTV18's top stocks to watch out for on October 14

Updated : 2019-10-14 08:18:12

Indian shares are likely to open mixed on Monday as investors turned cautious amid Q2 earnings and ahead of retail inflation data later in the day. Disappointing Q2 earnings from IT heavyweights and World Bank’s poor growth forecast for India may weigh on the equities. However, gains in global markets following progress in the US-China trade negotiations may support Indian shares. Asian shares rose after the US outlined the first phase of a deal to end a trade war with China and suspended a threatened tariff hike. At 7:31 AM, the SGX Nifty futures traded 24.50 points, or 0.22 percent, down at 11,284.50, indicating a mixed start for the Sensex and the Nifty50.

<strong>Infosys:</strong> Q2 net profit declined 2.2 percent to Rs 4,019 crore for the July-September 2019 quarter. Revenue rose 9.8 percent to Rs 22,629 crore in the quarter. In the constant currency terms, revenue rose 11.4 percent. Infosys also raised the lower-end of its FY2019-20 revenue guidance and the revised forecast now stands at 9-10 percent growth in constant currency terms. (Image: Reuters)
Infosys: Q2 net profit declined 2.2 percent to Rs 4,019 crore for the July-September 2019 quarter. Revenue rose 9.8 percent to Rs 22,629 crore in the quarter. In the constant currency terms, revenue rose 11.4 percent. Infosys also raised the lower-end of its FY2019-20 revenue guidance and the revised forecast now stands at 9-10 percent growth in constant currency terms. (Image: Reuters)
Avenue Supermarts: D-Mart owner posted a 47.54 percent year-on-year rise in net profit at Rs 322.63 crore for the quarter ended September 2019. Total Revenue or total income increased by 22.26 percent on a year-on-year (YoY) basis to Rs 5,998.90 crore. (Image: Company)
Avenue Supermarts: D-Mart owner posted a 47.54 percent year-on-year rise in net profit at Rs 322.63 crore for the quarter ended September 2019. Total Revenue or total income increased by 22.26 percent on a year-on-year (YoY) basis to Rs 5,998.90 crore. (Image: Company)
<strong>Cadila Healthcare:</strong> The USFDA inspected its API manufacturing facility at Dabhasa. This was a CGMP audit and a pre-approval inspection (PAI). At the end of the inspection, no observation (483) is issued. (Image: Company)
Cadila Healthcare: The USFDA inspected its API manufacturing facility at Dabhasa. This was a CGMP audit and a pre-approval inspection (PAI). At the end of the inspection, no observation (483) is issued. (Image: Company)
<strong>Bajaj Consumer:</strong> The net profit after tax for the quarter ended September 30 rose to 56 crore from Rs 50 crore a year ago. Revenue increased to Rs 220 crore for the second quarter compared to Rs 207 crore in the same period last year. (Stock image)
Bajaj Consumer: The net profit after tax for the quarter ended September 30 rose to 56 crore from Rs 50 crore a year ago. Revenue increased to Rs 220 crore for the second quarter compared to Rs 207 crore in the same period last year. (Stock image)
<strong>DLF:</strong> The realty major has sold 376 ready-to-move-in luxury flats worth Rs 700 crore on the first day of the launch of its new housing project in Gurugram. The company has launched the second phase of its luxury residential project Ultima. The second phase of this project comprises ready-to-move-in 3-4 bedroom apartments, priced at Rs 1.6 crore onwards. (Image: Company)
DLF: The realty major has sold 376 ready-to-move-in luxury flats worth Rs 700 crore on the first day of the launch of its new housing project in Gurugram. The company has launched the second phase of its luxury residential project Ultima. The second phase of this project comprises ready-to-move-in 3-4 bedroom apartments, priced at Rs 1.6 crore onwards. (Image: Company)
<strong>Torrent Pharma:</strong> The drug firm is recalling 73,896 bottles of hypertension treatment tablets from the US and Puerto Rico on account of deviations from current good manufacturing norms, according to a USFDA report. All these recalls are ongoing voluntary class II recalls, USFDA said. The reason for the recalls is,
Torrent Pharma: The drug firm is recalling 73,896 bottles of hypertension treatment tablets from the US and Puerto Rico on account of deviations from current good manufacturing norms, according to a USFDA report. All these recalls are ongoing voluntary class II recalls, USFDA said. The reason for the recalls is, "CGMP Deviations: FDA lab confirmed the presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million," it added. (Image: Company)
<strong>Reliance Capital:</strong> RCap’s securities business unit will buy the broking and distribution vertical of the company as part of the asset monetisation plan for Rs 164 crore. The sale process is expected to be completed by March 31, 2020, the company said. (Image: Reuters)
Reliance Capital: RCap’s securities business unit will buy the broking and distribution vertical of the company as part of the asset monetisation plan for Rs 164 crore. The sale process is expected to be completed by March 31, 2020, the company said. (Image: Reuters)
BASF India: The speciality chemical firm has received a Rs 613 crore tax demand from the Karnataka government for 2006-2015 period. The company has filed an appeal along with an application for grant of stay on recovery of demand pertaining to the period 2006-2010. The company has also filed a writ petition before the Karnataka High Court and has prayed for grant of stay on the demand notices. (Stock Image)
BASF India: The speciality chemical firm has received a Rs 613 crore tax demand from the Karnataka government for 2006-2015 period. The company has filed an appeal along with an application for grant of stay on recovery of demand pertaining to the period 2006-2010. The company has also filed a writ petition before the Karnataka High Court and has prayed for grant of stay on the demand notices. (Stock Image)
<strong>GOCL Corporation:</strong> IDL Explosives Ltd, a wholly-owned subsidiary of the company, has received an order worth Rs 375 crores from Coal India for supply of bulk explosives over a period of 2 years.
GOCL Corporation: IDL Explosives Ltd, a wholly-owned subsidiary of the company, has received an order worth Rs 375 crores from Coal India for supply of bulk explosives over a period of 2 years.
<strong>Concor, NEEPCO and THDC India:</strong> The government has kicked off strategic disinvestment exercise for this fiscal by inviting bids from advisers for sale of its controlling stake in three PSUs of Container Corporation of India (Concor), NEEPCO and THDC India.  Earlier this month, the Union Cabinet cleared a proposal of 30 per cent stake sale in Concor. Presently, the government has 54.80 per cent shareholding in the company and with the stake sale, the government will lose the management control. (File Photo: IANS)
Concor, NEEPCO and THDC India: The government has kicked off strategic disinvestment exercise for this fiscal by inviting bids from advisers for sale of its controlling stake in three PSUs of Container Corporation of India (Concor), NEEPCO and THDC India.  Earlier this month, the Union Cabinet cleared a proposal of 30 per cent stake sale in Concor. Presently, the government has 54.80 per cent shareholding in the company and with the stake sale, the government will lose the management control. (File Photo: IANS)
<strong>Bank of Baroda:</strong> The bank and BNP Paribas Asset Management Asia have entered into binding agreements to merge Baroda Asset Management and BNP Paribas Asset Management.
Bank of Baroda: The bank and BNP Paribas Asset Management Asia have entered into binding agreements to merge Baroda Asset Management and BNP Paribas Asset Management. "This joint venture will allow us to create a stronger, more competitive asset management company in the Indian mutual fund industry with the large distribution network of Bank of Baroda and the expertise of BNP Paribas coupled with the benefit of the firm's ability to source offshore funds," said P S Jayakumar, MD and CEO, Bank of Baroda. (Image: Reuters)
<strong>Maruti Suzuki India:</strong> It has received 10,000 bookings in 8 days for S-Presso, which was launched in India on September 30. The company also expects the current month to be better in terms of sales as compared with the same period last year, Shashank Srivastava, executive director of marketing and sales, told PTI.
Maruti Suzuki India: It has received 10,000 bookings in 8 days for S-Presso, which was launched in India on September 30. The company also expects the current month to be better in terms of sales as compared with the same period last year, Shashank Srivastava, executive director of marketing and sales, told PTI. "These are probably the green shoots and if we look at the first week of October, which was Navratara period, then bookings and retails have been better than last year as far as Navratra period goes," Srivastava said. (Image: Reuters)
Live TV

Ask Our Experts CNBC TV18